title: Role of intranasal topical steroid in pediatric sleep disordered breathing and influence of allergy, sinusitis, and obesity on treatment outcome.
abstract: OBJECTIVE
  To evaluate efficacy of short term intranasal corticosteroid (mometasone furoate) treatment in pediatric sleep-disordered breathing (SDB) patients.
  
  
  METHODS
  A prospective, observational study was done. A total of 41 children (2-11 years old) were enrolled into this study. All patients received 4-weeks course of mometasone furoate 100 µg/day treatment. They were evaluated at pretreatment and immediately after treatment with obstructive sleep apnea (OSA)-18 quality of life survey and lateral neck X-ray. Also, the assessment of each patients included history, skin prick test or CAP test, and sinus radiography. We compared the OSA-18 survey score and adenoidal-nasopharyngeal (AN) ratio between before and after treatment.
  
  
  RESULTS
  Total OSA-18 score and AN ratio decreased significantly after treatment regardless of allergy, sinusitis, and obesity (P=0.003, P=0.006). There was no complication after treatment of mometasone furoate.
  
  
  CONCLUSIONS
  Pediatric SDB patients with adenoid hypertrophy could be effectively treated with 4-weeks course of mometasone furoate. Allergy, obesity, and sinusitis did not affect on the result of treatment.
authors: Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Changwon Hospital, Changwon, Korea.
authors: Yong Gi
authors: YG
authors: Jung
authors: Hyo Yeol
authors: HY
authors: Kim
authors: Jin-Young
authors: JY
authors: Min
authors: Hun-Jong
authors: HJ
authors: Dhong
authors: Seung-Kyu
authors: SK
authors: Chung